Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty

Withdrawn before enrolling · Phase 2/Phase 3

Conditions studied: Osteoarthritis, Osteoarthritis, Knee, Arthritis, Degenerative, Osteoarthrosis, Osteoarthrosis Deformans

In brief

The purpose of the study is to evaluate the efficacy of local infiltration of liposomal bupivacaine versus use of an indwelling femoral peripheral nerve block in controlling early postoperative pain in primary total knee arthroplasty. The investigators hope to demonstrate equivalency of treatment modalities to provide an alternative to the commonly used treatment of femoral nerve blockade.

Key facts

Study ID

NCT02341079

Run by

United States Naval Medical Center, San Diego

People needed

0

Starts

2015-03-01

Expected to finish

2015-10-01

Last updated by the study team

2017-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age over 18 years old
• Undergoing unilateral primary total knee arthroplasty

You may not qualify if…

• Revision total knee arthroplasty
• Bilateral total knee arthroplasty
• Prior allergy or adverse reaction to local anesthetic
• Hepatic dysfunction

Where it is running

• Naval Medical Center San Diego — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.